Skip to main content
SpringerLink
Log in

High Volume Hemofiltration in Sepsis

  • Chapter
Intensive Care Medicine

  • 235 Accesses

Abstract

Continuous renal replacement therapy (CRRT) in the intensive care unit (ICU) is a common treatment in acute renal failure. CRRT is mainly conceived as merely supportive and as a replacement of the lost kidney function. On the other hand, evidence accumulated over recent years demonstrates that many soluble mediators of the systemic inflammatory (and anti-inflammatory) response syndrome (SIRS) can be removed by CRRT. This has led to the suggestion that CRRT could play a major role in sepsis therapy as an immunomodulatory treatment and not only as a blood purification technique. In this perspective, whereas animal studies yielded encouraging results, early clinical trials showed only minor clinical benefits, mainly dealing with hemodynamic improvements. The question of treatment dose has appropriately been raised as it remains undefined and a matter of controversy. A large-scale clinical trial has clarified issues on treatment dose in acute renal failure but a sufficiently powered study on hemofiltration dose in sepsis is still lacking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pinsky MR (2001) Sepsis: a pro-and anti-inflammatory disequilibrium syndrome. Contrib Nephrol 132: 354–366

    Article  PubMed  CAS  Google Scholar 

  2. Adrie C, Pinsky MR (2000) The inflammatory balance in human sepsis. Intensive Care Med 26: 364–375

    Article  PubMed  CAS  Google Scholar 

  3. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 15: 771–778

    Article  Google Scholar 

  4. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103: 565–575

    Google Scholar 

  5. Adib-Conquy M, Adrie C, Moine P, et al (2000) NF-kB expression in mononuclear cells of septic patients resembles that observed in LPS tolerance. Am J Respir Crit Care Med 162: 1877–1883

    Article  PubMed  CAS  Google Scholar 

  6. Van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Froelich M (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950–953

    Article  PubMed  Google Scholar 

  7. Klosterhalfen B, Horstmann-Jungemann K, Vogel P, et al (1991) Hemodynamic variables and plasma levels of PGI2, TXA2 and IL-6 in a porcine model of recurrent endotoxemia. Circ Shock 35: 237–244

    PubMed  CAS  Google Scholar 

  8. Abraham E, Matthay M, Dinarello CA, et al (2000) Consensus Conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 28: 232–235

    Article  PubMed  CAS  Google Scholar 

  9. Abraham E, Glauser MP, Butler T, et al (1997) p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45–2081 study group. JAMA 277: 1531–1538

    Google Scholar 

  10. Fisher CJ, Agosti JM, Opal SM (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. New Engl J Med 334: 1697–1702

    Google Scholar 

  11. Echtenacher B, Falk W, Mannel D, Krammer PH (1990) Requirement of endogenous tumour necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145: 3762–3766

    PubMed  CAS  Google Scholar 

  12. Van der Meer JWM (1988) The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection. Biotherapy 1: 19–25

    Article  PubMed  Google Scholar 

  13. Ronco C, Ricci Z, Bellomo R (2001) Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous hemofiltration. Curr Opin Nephrol Hypertens 10: 755–761

    Article  PubMed  CAS  Google Scholar 

  14. De Vriese AS, Vanholder RC, Pascual M, Lameire NH, Colardyn FA (1999) Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Med 25: 903–910

    Article  PubMed  Google Scholar 

  15. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1995) Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 48: 1563–1570

    Article  PubMed  CAS  Google Scholar 

  16. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA (1996) Complement depletion during haemofiltration with polyacetonitrile membranes. Nephrol Dial Transplant 11: 117–119

    Article  PubMed  CAS  Google Scholar 

  17. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR (1998) Diffusive vs. convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 26: 1995–2000

    Article  PubMed  CAS  Google Scholar 

  18. Goldfarb J, Golper TA (1994) Proinflammatory cytokines and hemofiltration membranes. Am Soc Nephrol 5: 228–232

    CAS  Google Scholar 

  19. Braun N, Giolai M, Rosenfeld S, et al (1993) Clearance of interleukin-6 during continuous veno-venous hemofiltration in patients with septic shock. A prospective, controlled clinical study. J Am Soc Nephrol 4: 336 (Abst)

    Google Scholar 

  20. Mariano F, Tetta C, Guida GE, Triolo G, Camussi G (2001) Hemofiltration reduces the priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 60: 15981605

    Google Scholar 

  21. Ronco C, Tetta C, Lupi A, et al (1995) Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23: 99–107

    Article  PubMed  CAS  Google Scholar 

  22. Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J (1997) Haemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23: 878–884

    Article  PubMed  CAS  Google Scholar 

  23. Heering P, Morgera S, Schmitz FJ, et al (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23: 288–296

    Article  PubMed  CAS  Google Scholar 

  24. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88: 1747–1754

    Article  PubMed  CAS  Google Scholar 

  25. Ronco C, Brendolan A, Lonnemann G, et al (2002) A randomized cross-over study on couplet plasma filtration with adsorption in septic shock. Crit Care Med (in press)

    Google Scholar 

  26. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LAM, van Osta ALM (1992) High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 7: 67–75

    Article  Google Scholar 

  27. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LAM, van Osta ALM (1992) High volume hemofiltration improves right ventricular function of endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240

    Article  PubMed  CAS  Google Scholar 

  28. Grootendorst AF, van Bommel EFH, van Leengoed LAM, van Zanten AR, Huipen HJ, Groeneveld AB (1993) Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 8: 161–169

    Article  PubMed  CAS  Google Scholar 

  29. Grootendorst AF, van Bommel EFH, van Leengoed LAM, Naburus M, Bouman CSC, Groeneveld ABJ (1994) High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72–78

    Article  PubMed  CAS  Google Scholar 

  30. Lee PA, Matson JR, Pryor RW, Hinshaw LB (1993) Continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21: 914–924

    Article  PubMed  CAS  Google Scholar 

  31. Rogiers P, Zhang H, Smail N, Auwels D, Vincent JL (1999) Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27: 1848–1855

    Article  PubMed  CAS  Google Scholar 

  32. Yekebas EF, Eisenberger CF, Ohnesorge H, et al (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29: 1423–1430

    Article  PubMed  CAS  Google Scholar 

  33. Nagashima M, Shin’oka T, Nollert G, Shum-Tim D, Rader CM, Mayer JE Jr (1998) High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation 98 (Suppl 19):II378–II384

    Google Scholar 

  34. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161: 1429–1436

    Article  PubMed  CAS  Google Scholar 

  35. Ronco C, Bellomo R, Homel P, et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26–30

    Article  PubMed  CAS  Google Scholar 

  36. Journois D, Israel Biet D, Pouard P, et al (1996) High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85: 965–976

    Article  PubMed  CAS  Google Scholar 

  37. Oudemans-van Straaten HM, Bosman RJ, van der Spoe JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25: 814–821

    Article  PubMed  CAS  Google Scholar 

  38. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM (1999) Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 56 (Suppl 72): S84 - S87

    Article  Google Scholar 

  39. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume hemofiltration in human septic shock. Intensive Care Med 27: 978–986

    Article  PubMed  CAS  Google Scholar 

  40. Honore PM, Jamez J, Wauthier M, et al (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 35813587

    Google Scholar 

  41. Guth HJ, Zschiesche M, Panzig E, Rudolph PE, Jager B, Kraatz G (1999) Which organic acids does hemofiltrate contain in the presence of acute renal failure? Int J Artif Organs 22: 805–810

    PubMed  CAS  Google Scholar 

  42. Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaefer RM (2000) Effects of bicarbonate-and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58: 1751–1757

    Article  PubMed  CAS  Google Scholar 

  43. Davenport A, Will EJ, Davison AM (1991) Hyperlactatemia and metabolic acidosis during hemofiltration using lactate-buffered fluids. Nephron 59: 461–465

    Article  PubMed  CAS  Google Scholar 

  44. Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP (2001) Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 29: 1513–1518

    Article  PubMed  CAS  Google Scholar 

  45. Soriano FG, Liaudet L, Marton A, et al (2001) Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med 29: 703–708

    Article  CAS  Google Scholar 

  46. Bellomo R, Baldwin I, Cole L, Ronco C (1998) Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 53 (Suppl 66): 182–185

    Google Scholar 

  47. Lee PA, Weger G, Pryor RW, Matson JR (1998) Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 26: 730–737

    Article  PubMed  CAS  Google Scholar 

  48. Kline JA, Gordon BE, Williams C, Blumenthal S, Watts JA, Diaz-Buxo J (1999) Large-pore hemodialysis in acute endotoxin shock. Crit Care Med 27: 588–596

    Article  PubMed  CAS  Google Scholar 

  49. Morgera S, Buder W, Lehmann C, et al (2000) High cut off membrane haemofiltration in septic patients with multiorgan failure. A preliminary report. Blood Purif 18: 61 (Abst)

    Google Scholar 

  50. High Volume Hemofiltration in Sepsis 141

    Google Scholar 

  51. Reeves JH, Butt WW, Shann F, et al (1999) Continuous plasmafiltration in sepsis syndrome. Crit Care Med 27: 2096–2104

    Article  PubMed  CAS  Google Scholar 

  52. Tetta C, Cavaillon JM, Schulze M, et al (1998) Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 13: 1458–1464

    Article  PubMed  CAS  Google Scholar 

  53. Tetta C, Gianotti L, Cavaillon JM, et al (2000) Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 28: 1526–1533

    Article  PubMed  CAS  Google Scholar 

  54. Brendolan A, Bellomo R, Tetta C, et al (2001) Coupled plasma filtration adsorption in the treatment of septic shock. Contrib Nephrol 132: 383–390

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K. Reiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Bellomo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Ronco
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent MD, PhD, FCCM, FCCP (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Reiter, K., Bellomo, R., Ronco, C. (2002). High Volume Hemofiltration in Sepsis. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5551-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5551-0_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-5553-4

  • Online ISBN: 978-1-4757-5551-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation